Program Outline
Topic: Management of High Risk Breast Cancer Patients
The journal club is meant to foster dynamic dialogue and clinical debate.
Oncology is an ever-evolving study of medicine. Many papers have helped shape up the stream of medicine.
Over the years we have stumbled over papers which have given us the opportunity to develop our understanding and improve.
Once a month we will organize the EIOC Journal Club, where these papers will be reviewed.
29 April, 2024 Journal Club
"Supported By"
Upcoming Events
The next EIOC Journal Club is scheduled to be held in the month of April 2024. The topic and Panelists will be announced later. Stay tuned!
View our Past Events
The EIOC Journal Club was organized on 25 March 2024, where a panel of 3 speakers discusses on current paper revolving around Optimal Patient Selection for Lu-PSMA Therapy
The EIOC Journal Club was organized on 14 March 2024, where a panel of 7 speakers discusses on current paper revolving around Clinical Pearls on CDK4/6 Inhibitor Selection and Treatment in early and metastatic HR+, HER2- Breast Cancer
The EIOC Journal Club was organized on 13 March 2024, where a panel of 3 speakers discusses on current paper revolving around Immunotherapies Sequencing in NSCLC: From Early to Metastatic Setting
The EIOC Journal Club was organized on 15 January 2024, where a panel of 4 speakers discusses on current paper revolving around Transforming mTNBC Horizons
The EIOC – In Conversation Series was organized on 20 December 2023, where a panel of 2 speakers discusses on latest updates revolving around Interpreting ESMO 2023 – Focusing on Gynecologic Cancer
The EIOC Journal Club was organized on 12 December 2023, where a panel of 7 speakers discusses on current paper revolving around Latest updates from ESMO and SABCS for HR+ HER2 -EBC Management
The EIOC – In Conversation Series was organized on 27 November 2023, where a panel of 2 speakers discusses on latest updates revolving around Interpreting ESMO 2023 – Focusing on Lung Cancer
The EIOC Journal Club was organized on 23 November 2023, where a panel of 7 speakers discusses on current paper revolving around Evolving Trends and Updates in Precision Medicine and NSCLC
The EIOC – In Conversation Series was organized on 20 November 2023, where a panel of 3 speakers discusses on latest updates revolving around Interpreting ESMO 2023 – Focusing on Breast Cancer
The EIOC Journal Club was organized on 16 October 2023, where a panel of 6 speakers discusses on current paper revolving around Combination PARPI Strategies in metastatic castration- resistant prostate cancer: integrating data into clinical practice!
The EIOC Journal Club was organized on 18 September 2023, where a panel of 6 speakers discusses on current paper revolving around Optimal Integration of the Approved Oral SERDs in Routine Clinical Practice
The EIOC Journal Club was organized on 07 September 2023, where a panel of 6 speakers discusses on current paper revolving around Practical Consideration and Therapy Management of CDK4/6i in MBC Setting
The EIOC Journal Club was organized on 14 August 2023, where a panel of 6 speakers discusses on current paper revolving around Treatment Selection & Sequencing in High-Risk gBRCAm HR+, HER2- eBC and gBRCAm eTNBC
The EIOC Journal Club was organized on 23 June 2023, where a panel of 7 speakers discusses on current paper revolving around From Bench to Bedside: The Future for High Risk Patients in Early Breast Cancer.
The EIOC Journal Club was organized on 22 June 2023, where a panel of 10 speakers discusses on current paper revolving around Latest Updates of CDK4/6 Inhibitors in the Management of HR+ HER2- eBC.
The EIOC Journal Club was organized on 12 June 2023, where a panel of 4 speakers discusses on current paper revolving around Highlights & Updates from ASCO: Key Abstracts & Presentations.
The EIOC Journal Club was organized on 29 May 2023, where a panel of 6 speakers discusses on current paper revolving around IO in Upper GI Cancer Management.
The EIOC Journal Club was organized on 17 May 2023, where a panel of 4 speakers discusses on current paper revolving around Is Liquid Now Solid? Recent Updates on the Clinical Applications of Liquid Biopsies for Precision Oncology in Advanced NSCLC.
The EIOC Journal Club was organized on 08 May 2023, where a panel of 4 speakers discusses on current paper revolving around Updated in the Management of mHSPC.
The EIOC Journal Club was organized on 17 April 2023, where a panel of 8 speakers discusses on current paper revolving around Optimal Sequencing of Therapy in HER2 Low mBC.
The EIOC Journal Club was organized on 20 March 2023, where a panel of 4 speakers discusses on current paper revolving around High-Risk Breast Cancer Highlights in Early and Advanced Setting
The EIOC Journal Club was organized on 06 March 2023, where a panel of 6 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early-Stage Breast Cancer
The EIOC Journal Club was organized on 28 February 2023, where a panel of 4 speakers discusses on current paper revolving around Management of HER2+ Metastatic Breast Cancer Patients
The EIOC Journal Club was organized on 22 February 2023, where a panel of 5 speakers discusses on current paper revolving around Management of HR+ HER2- mBC Patients
The EIOC Journal Club was organized on 13 February 2023, where a panel of 4 speakers discusses on current paper revolving around Current Treatment Paradigm for HER2+ Early BC & mBC
The EIOC Journal Club was organized on 19 December 2022, where a panel of 6 speakers discusses on current paper revolving around Integration of the Latest Evidence into the Management of Metastatic Triple Negative Breast Cancer.
The EIOC Journal Club was organized on 14 October 2022, where a panel of 11 speakers discusses on current paper revolving around Management of HER2 Low Breast Cancer
The EIOC Journal Club was organized on 08 July 2022, where a panel of 6 speakers discusses on current paper revolving around Highlights & Updates from ASCO: Key Abstracts & Presentations
The EIOC Journal Club was organized on 02 July 2022, where a panel of 6 speakers discusses on current paper revolving around Shifting Perspectives in HR+/HER2- Advanced Breast Cancer
The EIOC Journal Club was organized on 10 June 2022, where a panel of 6 speakers discusses on current paper revolving around Role of Immunotherapy in NSCLC
The EIOC Journal Club was organized on 27 May 2022, where a panel of 7 speakers discusses on current paper revolving around Making Precision Oncology the Standard of Care
The EIOC Journal Club was organized on 20 May 2022, where a panel of 6 speakers discusses on current paper revolving around Increasing Access to Breast Cancer Treatment through Biosimilars
The EIOC Journal Club was organized on 22 April 2022, where a panel of 5 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early Stage Breast Cancer
The EIOC Journal Club was organized on 25 February 2022, where a panel of 9 speakers discusses on current paper revolving around Clinical Utility of ctDNA for CRC and Immunotherapy response monitoring
The sixth EIOC Journal Club was organized on 4 December 2021, where a panel of 11 speakers discusses on current paper revolving around Optimising Therapy in Hormone Receptor Positive Breast Cancer
The fifth EIOC Journal Club was organized on 28 August 2021, where a panel of 11 speakers discusses on current paper revolving around Deconstructing OlympiA and IO in early-stage TNBC : Is it time to change practice?
The fouth EIOC Journal Club was organized on 16 July 2021, where a panel of 8 speakers discusses on current paper revolving around Immunotherapy and Targeted Approaches for Gynae Malignancies
The third EIOC Journal Club was organized on 2 July 2021, where a panel of 10 speakers discusses on current paper revolving around “Hormone receptive positive Breast Cancer”
The second EIOC Journal Club was organized on 25 June 2021, where a panel of 10 speakers discusses on current paper revolving around Triple- Negative and HER2 positive Breast Cancer
The first EIOC Journal Club was organized on 21 May 2021, where a panel of 10 speakers discusses on current paper revolving around Genomic Testing, Ovarian Function Suppression, Hormone receptor positive HER2 – eBC.
Disclaimer :
This site does not recommend, endorse or promote any particular management approach, methodology or treating agents. The views expressed by various experts are their own.